Literature DB >> 1845870

Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism.

G T Everson1, C McKinley, F Kern.   

Abstract

Our aim was to define mechanisms whereby conjugated estrogens (Premarin, exogenous estrogen; Ayerst Laboratories, New York) increase the risk of developing cholesterol gallstones and to determine the role, if any, of dietary cholesterol. We studied gallbladder motor function, biliary lipid composition and secretion, cholesterol absorption, cholesterol synthesis and esterification by peripheral blood mononuclear cells, the clearance of chylomicron remnants, and bile acid kinetics in 29 anovulatory women. 13 were studied on both a low (443 +/- 119 mumol/d) and high (2,021 +/- 262 mumol/d) cholesterol diet. Premarin increased the lithogenic index of bile (P less than 0.05), increased biliary cholesterol secretion (P less than 0.005), lowered chenodeoxycholate (CDCA) pool (P less than 0.001) and synthesis (P less than 0.05), altered biliary bile acid composition [( CA + DCA]/CDCA increases, P less than 0.005), stimulated cholesterol esterification (P less than 0.03), and enhanced the clearance of chylomicron remnants (P = 0.07). Increases in dietary cholesterol stimulated the biliary secretion of cholesterol (P = 0.07), bile acid (P less than 0.05), phospholipid (P = 0.07), and as a result, did not alter lithogenic index. The reduction in CDCA pool and synthesis by Premarin was reversed by increasing dietary cholesterol. Off Premarin, only 24% of the increase in cholesterol entering the body in the diet was recovered as biliary cholesterol or newly synthesized bile acid. On Premarin, 68% of this increase in cholesterol was recovered as these biliary lipids. We conclude that Premarin increases biliary cholesterol by enhancing hepatic lipoprotein uptake and inhibiting bile acid synthesis. These actions of Premarin divert dietary cholesterol into bile.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1845870      PMCID: PMC295035          DOI: 10.1172/JCI114977

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  58 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  A physiological method for estimation of hepatic secretion of biliary lipids in man.

Authors:  S M Grundy; A L Metzger
Journal:  Gastroenterology       Date:  1972-06       Impact factor: 22.682

3.  Bile acid secretion by cultured rat hepatocytes. Regulation by cholesterol availability.

Authors:  R A Davis; P M Hyde; J C Kuan; M Malone-McNeal; J Archambault-Schexnayder
Journal:  J Biol Chem       Date:  1983-03-25       Impact factor: 5.157

4.  Effect of synthetic oestrogens and progestagens in oral contraceptives on bile lipid composition.

Authors:  R H Down; M J Whiting; J M Watts; W Jones
Journal:  Gut       Date:  1983-03       Impact factor: 23.059

5.  The epidemiology of gallbladder disease: observations in the Framingham Study.

Authors:  G D Friedman; W B Kannel; T R Dawber
Journal:  J Chronic Dis       Date:  1966-03

6.  Effects of dietary cholesterol on the regulation of total body cholesterol in man.

Authors:  E Quintão; S M Grundy; E H Ahrens
Journal:  J Lipid Res       Date:  1971-03       Impact factor: 5.922

7.  The effect of a progestin on gallbladder function in young women.

Authors:  E A Shaffer; P J Taylor; K Logan; S Gadomski; B Corenblum
Journal:  Am J Obstet Gynecol       Date:  1984-03-01       Impact factor: 8.661

8.  Contraceptive steroids increase hepatic uptake of chylomicron remnants in healthy young women.

Authors:  F Berr; R H Eckel; F Kern
Journal:  J Lipid Res       Date:  1986-06       Impact factor: 5.922

9.  Plasma lipoprotein retinoids after vitamin A feeding in normal man: minimal appearance of retinyl esters among low-density lipoproteins.

Authors:  D E Wilson; I F Chan; M Ball
Journal:  Metabolism       Date:  1983-05       Impact factor: 8.694

10.  Effects of acute changes of bile acid pool composition on biliary lipid secretion.

Authors:  N Carulli; P Loria; M Bertolotti; M Ponz de Leon; D Menozzi; G Medici; I Piccagli
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

View more
  47 in total

1.  Altered cholesterol metabolism in patients with cholesterol gallstones: responses to reduced dietary cholesterol.

Authors:  F Kern
Journal:  Trans Am Clin Climatol Assoc       Date:  1993

2.  Changes of lipid metabolism in plasma, liver and bile during cholesterol gallstone formation in rabbit model.

Authors:  Ji-Chun Zhao; Lu-Jia Xiao; Hong Zhu; Ye Shu; Nan-Sheng Cheng
Journal:  World J Gastroenterol       Date:  1998-08       Impact factor: 5.742

3.  Estrogen induces two distinct cholesterol crystallization pathways by activating ERα and GPR30 in female mice.

Authors:  Ornella de Bari; Tony Y Wang; Min Liu; Piero Portincasa; David Q-H Wang
Journal:  J Lipid Res       Date:  2015-07-07       Impact factor: 5.922

4.  Postmenopausal estrogen therapy and risk of gallstone disease: a population-based case-control study.

Authors:  Maja Hellfritzsch Simonsen; Rune Erichsen; Trine Frøslev; Jørgen Rungby; Henrik Toft Sørensen
Journal:  Drug Saf       Date:  2013-12       Impact factor: 5.606

5.  Role of the estrogen and progestin in hormonal replacement therapy on apolipoprotein A-I kinetics in postmenopausal women.

Authors:  Stefania Lamon-Fava; Borbala Postfai; Margaret Diffenderfer; Carl DeLuca; John O'Connor; Francine K Welty; Gregory G Dolnikowski; P Hugh R Barrett; Ernst J Schaefer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-12-08       Impact factor: 8.311

6.  Alterations in gallbladder emptying and bile retention in the absence of changes in bile lithogenicity in postmenopausal women on hormone replacement therapy.

Authors:  Radha K Dhiman; Pralay K Sarkar; Arpita Sharma; Kala Vasishta; Krishan K Kohli; Sanjay Gupta; Sudha Suri; Yogesh Chawla
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

7.  Prevalence of gastrointestinal diseases in two British national birth cohorts.

Authors:  A G C Ehlin; S M Montgomery; A Ekbom; R E Pounder; A J Wakefield
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

8.  Reproductive factors and risks of biliary tract cancers and stones: a population-based study in Shanghai, China.

Authors:  G Andreotti; L Hou; Y-T Gao; L A Brinton; A Rashid; J Chen; M-C Shen; B-S Wang; T-Q Han; B-H Zhang; L C Sakoda; J F Fraumeni; A W Hsing
Journal:  Br J Cancer       Date:  2010-03-09       Impact factor: 7.640

Review 9.  Genetic analysis of cholesterol gallstone formation: searching for Lith (gallstone) genes.

Authors:  David Q-H Wang; Nezam H Afdhal
Journal:  Curr Gastroenterol Rep       Date:  2004-04

10.  ESWL and oral dissolution therapy. What factors influence results?

Authors:  A Buttmann; H E Adamek; J Weber; J F Riemann
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.